INSIGHTS
Insights that cut through complexity
Menu
Want the lowest-net-cost drugs? Change your thinking on disruption
It might seem like a lowest-net-cost formulary would be made up of clinically equivalent agents with the lowest overall cost.…
COVID-19 Treatment Developments
Introduction Recent data from Johns Hopkins University showed over 760,000 people in the U.S. have died from the coronavirus to…
Q3 2021 Drug Pipeline Recap
The Latest Developments in Drug Approvals Each quarter, the RemedyOne Clinical team curates a drug pipeline report for our clients…
No One Really Knows How We’ll Pay for Gene Therapies
Gene therapies are here and they have the potential to be miraculous. And extremely expensive. The science behind these therapies…
COVID-19 Treatment Update
The last year and a half brought many rapid changes and innovations across the globe and in no area more than healthcare. From finding the most effective treatments to developing tests and…
The Implications of Polypharmacy on the Payor and Patient
There is a delicate balance between prescribing new medications and identifying and eliminating unnecessary prescriptions to protect the overall care…
Like what you’re seeing?
Get more Insights sent to you.
